GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Clinical trials employing cancer vaccine combination therapies

$846,484
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Targeting microbial triggers of gammopathy for immunoprevention

$846,118
Madhav V Dhodapkar · Fred Hutchinson Cancer Center · UG3 · FY2025 · CA

Human Immune Responses to Tumor Antigens for Cancer Immunotherapy

$845,528
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Intercepting progression from pre-invasive to invasive lung adenocarcinoma

$845,268
Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · UH3 · FY2021 · CA

Role of inflammation in epigenetic alterations of metastatic cancer cells

$845,247
Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta

$845,247
Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Single-cell Analysis of Normal and Perturbed Dynamic and Spatial Biological Systems

$845,220
Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity

$844,970
David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2021 · CA

METEOR-BioLogical Specimen Translation (METEOR-BLST)

$844,906
Michael Benjamin Major · Washington University · U54 · FY2025 · CA

The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia

$844,895
Marcus Dasilva Goncalves · New York University School Of Medicine · OT2 · FY2025 · CA

Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis

$844,766
Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2021 · HL

Preclinical development of breakthrough immunotherapy for brain tumors

$844,555
Hideho Okada · University Of California, San Francisco · R35 · FY2024 · NS

Making cancer precision medicine real: bottlenecks and opportunities

$844,357
Todd R. Golub · Broad Institute, Inc. · R35 · FY2021 · CA

Role of Tumor Stroma in Therapeutic Response and Resistance

$843,318
Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA

ALTERING THE TUMOR MICROENVIRONMENT TO AUGMENT NEUROBLASTOMA IMMUNOTHERAPY

$842,500
Children'S Hospital Los Angeles · · FY2018 · Department of the Army

The role of coherent angular motion in adult tissue remodeling

$841,360
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors

$841,065
Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA

Biomechanical properties of chromatin in cancer and normal cells

$839,808
Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Modulation of Therapeutic Response

$839,713
James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

Decoding the cellular mechanisms of COVID-19 severe disease susceptibility in patients with chronic respiratory disease

$839,491
Alexander Minchev Tsankov · Icahn School Of Medicine At Mount Sinai · R56 · FY2021 · HL

Development of TGF-beta antagonists for cancer therapy

$839,111
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Molecular diagnosis and outcome prediction in lymphoma

$838,914
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Tumor microenvironments determing migration, dissemination and dormancy

$838,472
John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2011 · CA

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides

$837,803
Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Intracellular In vivo Imaging

$837,139
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA